-
Je něco špatně v tomto záznamu ?
Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases
I. Agache, I. Annesi-Maesano, A. Bonertz, F. Branca, A. Cant, Z. Fras, F. Ingenrieth, L. Namazova-Baranova, M. Odemyr, A. Spanevello, S. Vieths, A. Yorgancioglu, M. Alvaro-Lozano, D. Barber Hernandez, T. Chivato, S. Del Giacco, Z. Diamant, I....
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články, přehledy
PubMed
31070805
DOI
10.1111/all.13856
Knihovny.cz E-zdroje
- MeSH
- alergie diagnóza epidemiologie etiologie terapie MeSH
- big data MeSH
- bioinženýrství MeSH
- bronchiální astma diagnóza epidemiologie terapie MeSH
- environmentální zdraví MeSH
- implementační věda MeSH
- informační technologie MeSH
- kapitálové financování * MeSH
- lidé MeSH
- management nemoci MeSH
- translační biomedicínský výzkum * ekonomika zákonodárství a právo metody organizace a řízení MeSH
- vyvíjení léků MeSH
- výzkum * MeSH
- zapojení pacienta MeSH
- zdravotní politika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Evropa MeSH
The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients' organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.
Aimmune Therapeutics London UK
Allergy Therapeutics Worthing UK Bencard Allergie GmbH Munich Germany
Department of Medical Sciences and Public Health University of Cagliari Cagliari Italy
Department of Nutrition for Health and Development Geneva Switzerland WHO HQ Geneva Switzerland
Department of Pathophysiology and Allergy Research Medical University of Vienna Vienna Austria
Department of Pulmonology Celal Bayar University School of Medicine Manisa Turkey
Dermatology and Allergology Helsinki University Hospital and University of Helsinki Helsinki Finland
European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium
European Medical Affairs Sanofi Milan Italy
Federal Agency for Vaccines and Biomedicines Paul Ehrlich Institut Langen Germany
Global Allergy and Asthma Patient Platform Vienna Austria
Institute of Translational Pharmacology Italian National Research Council Rome Italy
Royal Brompton and Harefield NHS Foundation Trust London UK Imperial College London UK
School of Medicine University CEU San Pablo Madrid Spain
SCOPE Europe Bruxelles Belgium
Severe Asthma Unit Complejo Hospitalario de Navarra Pamplona Spain
Transylvania University Brasov Romania
Zentrums Allergie and Umwelt Technische Universität und Helmholtz Zentrum München Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025512
- 003
- CZ-PrNML
- 005
- 20201222160239.0
- 007
- ta
- 008
- 201125s2019 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/all.13856 $2 doi
- 035 __
- $a (PubMed)31070805
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Agache, Ioana $u Transylvania University, Brasov, Romania.
- 245 10
- $a Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases / $c I. Agache, I. Annesi-Maesano, A. Bonertz, F. Branca, A. Cant, Z. Fras, F. Ingenrieth, L. Namazova-Baranova, M. Odemyr, A. Spanevello, S. Vieths, A. Yorgancioglu, M. Alvaro-Lozano, D. Barber Hernandez, T. Chivato, S. Del Giacco, Z. Diamant, I. Eguiluz-Gracia, RG. van Wijk, P. Gevaert, A. Graessel, P. Hellings, K. Hoffmann-Sommergruber, M. Jutel, S. Lau, A. Lauerma, J. Maria Olaguibel, L. O'Mahony, C. Ozdemir, O. Palomares, O. Pfaar, J. Sastre, G. Scadding, C. Schmidt-Weber, P. Schmid-Grendelmeier, M. Shamji, I. Skypala, M. Spinola, O. Spranger, M. Torres, A. Vereda, S. Bonini,
- 520 9_
- $a The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients' organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.
- 650 _2
- $a bronchiální astma $x diagnóza $x epidemiologie $x terapie $7 D001249
- 650 _2
- $a big data $7 D000077558
- 650 _2
- $a bioinženýrství $7 D057005
- 650 12
- $a kapitálové financování $7 D002202
- 650 _2
- $a management nemoci $7 D019468
- 650 _2
- $a vyvíjení léků $7 D000076722
- 650 _2
- $a environmentální zdraví $7 D004782
- 650 _2
- $a zdravotní politika $7 D006291
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a alergie $x diagnóza $x epidemiologie $x etiologie $x terapie $7 D006967
- 650 _2
- $a implementační věda $7 D000077626
- 650 _2
- $a informační technologie $7 D000073256
- 650 _2
- $a zapojení pacienta $7 D010358
- 650 12
- $a výzkum $7 D012106
- 650 12
- $a translační biomedicínský výzkum $x ekonomika $x zákonodárství a právo $x metody $x organizace a řízení $7 D057170
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Annesi-Maesano, Isabella $u Department of Epidemiology of Allergic and Respiratory Diseases, Medical School Saint Antoine, IPLESP, INSERM and Sorbonne Université, Paris, France.
- 700 1_
- $a Bonertz, Andreas $u Federal Agency for Vaccines and Biomedicines, Paul-Ehrlich-Institut, Langen, Germany.
- 700 1_
- $a Branca, Francesco $u Department of Nutrition for Health and Development, Geneva, Switzerland. WHO/HQ, Geneva, Switzerland.
- 700 1_
- $a Cant, Andrew $u University of Newcastle Upon Tyne, Newcastle upon Tyne, UK. European Society for Immunodeficiencies, Geneva, Switzerland.
- 700 1_
- $a Fras, Zlatko $u Division of Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia. Medical Faculty, University of Ljubljana, Ljubljana, Slovenia. UEMS - Union Europeenne des Medecins Specialistes/European Union of Medical Specialists, Brussels, Belgium.
- 700 1_
- $a Ingenrieth, Frank $u SCOPE Europe, Bruxelles, Belgium.
- 700 1_
- $a Namazova-Baranova, Leyla $u Department of Pediatrics, Russian National Research Medical University of MoH RF, Moscow, Russia. Department of Pediatrics, Central Clinical Hospital of MoSHE (Ministry of Science and High Education), Moscow, Russian Federation.
- 700 1_
- $a Odemyr, Mikaela $u European Federation of Allergy and Airways Diseases Patients' Associations (EFA), Brussels, Belgium.
- 700 1_
- $a Spanevello, Antonio $u Dipartimento di Medicina e Chirurgia, Malattie dell'Apparato Respiratorio, Università degli Studi dell'Insubria, Varese - Como, Italy. Dipartimento di Medicina e Riabilitazione Cardio Respiratoria, U.O. di Pneumologia Riabilitativa, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, Tradate, Italy.
- 700 1_
- $a Vieths, Stefan $u Federal Agency for Vaccines and Biomedicines, Paul-Ehrlich-Institut, Langen, Germany.
- 700 1_
- $a Yorgancioglu, Arzu $u Department of Pulmonology, Celal Bayar University School of Medicine, Manisa, Turkey.
- 700 1_
- $a Alvaro-Lozano, Montserat $u Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Barcelona, Spain.
- 700 1_
- $a Barber Hernandez, Domingo $u Department of Basic Medical Sciences, School of Medicine, Universidad CEU San Pablo, Madrid, Spain. RETIC ARADYAL RD16/0006/0015, Instituto de Salud Carlos III, Madrid, Spain.
- 700 1_
- $a Chivato, Tomás $u School of Medicine, University CEU San Pablo, Madrid, Spain.
- 700 1_
- $a Del Giacco, Stefano $u Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
- 700 1_
- $a Diamant, Zuzana $u Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden. Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
- 700 1_
- $a Eguiluz-Gracia, Ibon $u Allergy Unit, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain. ARADyAL Network RD16/0006/0001, Carlos III Health Institute, Madrid, Spain.
- 700 1_
- $a van Wijk, Roy Gert $u Section of Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
- 700 1_
- $a Gevaert, Philippe $u Department of Otorhinolaryngology-Head and Neck Surgery, Upper Airways Research Laboratory, Ghent University, Ghent, Belgium.
- 700 1_
- $a Graessel, Anke $u Allergy Therapeutics, Worthing, UK. Bencard Allergie GmbH, Munich, Germany.
- 700 1_
- $a Hellings, Peter $u Department of Otorhinolaryngology-Head and Neck Surgery, Upper Airways Research Laboratory, Ghent University, Ghent, Belgium. Department of Otorhinolaryngology-Head and Neck Surgery, UZ Leuven, Leuven, Belgium. Department of Otorhinolaryngology, Academic Medical Center, Amsterdam, The Netherlands.
- 700 1_
- $a Hoffmann-Sommergruber, Karin $u Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Jutel, Marek $u Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland. "ALL-MED" Medical Research Institute, Wroclaw, Poland.
- 700 1_
- $a Lau, Susanne $u Department for Pediatric Pneumology, Immunology and Intensive Care, Charité Universität Medizin, Berlin, Germany.
- 700 1_
- $a Lauerma, Antti $u Dermatology and Allergology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- 700 1_
- $a Maria Olaguibel, Jose $u Severe Asthma Unit, Complejo Hospitalario de Navarra, Pamplona, Spain.
- 700 1_
- $a O'Mahony, Liam $u Departments of Medicine and Microbiology, APC Microbiome Ireland, National University of Ireland, Cork, Ireland.
- 700 1_
- $a Ozdemir, Cevdet $u Department of Pediatric Basic Sciences, Institute of Child Health, Istanbul University, Istanbul, Turkey. Department of Pediatrics, Division of Pediatric Allergy & Immunology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- 700 1_
- $a Palomares, Oscar $u Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain.
- 700 1_
- $a Pfaar, Oliver $u Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
- 700 1_
- $a Sastre, Joaquin $u Department of Allergy, Fundación Jimenez Diaz, Madrid, Spain. Department of Medicine, Instituto Carlos III, CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.
- 700 1_
- $a Scadding, Glennis $u RNTNE Hospital, London, UK.
- 700 1_
- $a Schmidt-Weber, Carsten $u Zentrums Allergie & Umwelt (ZAUM), Technische Universität und Helmholtz Zentrum, München, Germany.
- 700 1_
- $a Schmid-Grendelmeier, Peter $u Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland. Christine-Kühne Center for Allergy Research and Education CK-CARE Davos, Davos, Switzerland.
- 700 1_
- $a Shamji, Mohamed $u Allergy & Clinical Immunology, Inflammation, Repair and Development, Imperial College, National Heart and Lung Institute, Immunomodulation and Tolerance Group, London, UK. Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK.
- 700 1_
- $a Skypala, Isabel $u Royal Brompton & Harefield NHS Foundation Trust, London, UK. Imperial College, London, UK.
- 700 1_
- $a Spinola, Monica $u European Medical Affairs, Sanofi, Milan, Italy.
- 700 1_
- $a Spranger, Otto $u Global Allergy and Asthma Patient Platform, Vienna, Austria.
- 700 1_
- $a Torres, Maria $u Allergy Unit, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain. ARADyAL Network RD16/0006/0001, Carlos III Health Institute, Madrid, Spain.
- 700 1_
- $a Vereda, Andrea $u Aimmune Therapeutics, London, UK.
- 700 1_
- $a Bonini, Sergio $u Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy.
- 773 0_
- $w MED00009088 $t Allergy $x 1398-9995 $g Roč. 74, č. 11 (2019), s. 2064-2076
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31070805 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222160234 $b ABA008
- 999 __
- $a ok $b bmc $g 1599657 $s 1116198
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 74 $c 11 $d 2064-2076 $e 20190602 $i 1398-9995 $m Allergy $n Allergy $x MED00009088
- LZP __
- $a Pubmed-20201125
